MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202611000255 A) filed by Poonam Arora; Dr Vaanssh Arora; and Dr Shailender Arora, New Delhi, on Jan. 2, for 'novel topical formulation combining high-strength minoxidil, latanoprost, tretinoin, and human placental extract for synergistic promotion of hair regrowth in alopecia.'
Inventor(s) include Poonam Arora; Dr Vaanssh Arora; and Dr Shailender Arora.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "This novel hair growth formulation introduces an innovative combination of minoxidil, latanoprost, tretinoin and human placenta extract that synergistically promotes hair follicle stimulation, improves scalp absorption, and enhances overall hair regrowth outcomes in patients experiencing alopecia or hair loss conditions. The unique multi-component system leverages enhanced penetration of active ingredients into hair follicles while providing nourishing support through placental growth factors. [510] By strategically incorporating tretinoin to boost penetration alongside placental extract to provide essential nutrients and growth signals, this advanced topical solution amplifies the established hair growth effects of minoxidil and latanoprost. The composition is optimized for once daily application and demonstrates significant improvement in hair density, thickness, and growth rate with a favorable tolerability profile. [515] This groundbreaking formulation establishes a new standard of care for topical alopecia treatment by combining high concentrations of evidence-based therapies with innovative natural ingredients in a proprietary delivery vehicle. Through this multi-targeted approach, the invention comprehensively addresses the multifactorial nature of hair loss to achieve superior hair regrowth compared to existing treatment options."
Disclaimer: Curated by HT Syndication.
